Broadleaf Partners’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,131
Closed -$3.53M 81
2024
Q1
$3.53M Sell
7,131
-4,481
-39% -$2.28M 0.9% 38
2023
Q4
$6.11M Buy
11,612
+4,354
+60% +$2.32M 1.79% 22
2023
Q3
$3.66M Sell
7,258
-7,427
-51% -$3.66M 1.22% 32
2023
Q2
$7.06M Buy
14,685
+21
+0.1% +$10.3K 2.3% 22
2023
Q1
$6.93M Buy
14,664
+254
+2% +$123K 2.47% 17
2022
Q4
$7.64M Sell
14,410
-190
-1% -$101K 3.01% 11
2022
Q3
$7.37M Sell
14,600
-29
-0.2% -$15.2K 3.07% 9
2022
Q2
$7.51M Buy
14,629
+328
+2% +$165K 3.14% 9
2022
Q1
$7.29M Buy
14,301
+9
+0.1% +$4.34K 2.43% 16
2021
Q4
$7.18M Sell
14,292
-109
-0.8% -$49.3K 2.2% 19
2021
Q3
$5.63M Buy
14,401
+575
+4% +$238K 1.86% 23
2021
Q2
$5.54M Sell
13,826
-437
-3% -$174K 1.92% 21
2021
Q1
$5.31M Buy
14,263
+526
+4% +$182K 2% 22
2020
Q4
$4.82M Buy
13,737
+5
+0% +$1.68K 1.9% 23
2020
Q3
$4.28M Sell
13,732
-103
-0.7% -$31.6K 1.89% 21
2020
Q2
$4.08M Buy
13,835
+128
+0.9% +$36.7K 2% 19
2020
Q1
$3.42M Sell
13,707
-8,877
-39% -$2.44M 2.2% 19
2019
Q4
$6.64M Buy
22,584
+3,765
+20% +$985K 3.63% 7
2019
Q3
$4.09M Buy
18,819
+455
+2% +$110K 2.56% 15
2019
Q2
$4.48M Buy
18,364
+5,485
+43% +$1.32M 2.87% 11
2019
Q1
$3.18M Sell
12,879
-118
-0.9% -$30.1K 2.22% 23
2018
Q4
$3.24M Buy
12,997
+1,794
+16% +$474K 2.59% 14
2018
Q3
$2.98M Sell
11,203
-249
-2% -$64.8K 2% 23
2018
Q2
$2.81M Buy
11,452
+61
+0.5% +$14.6K 2.06% 23
2018
Q1
$2.44M Sell
11,391
-71
-0.6% -$16.2K 1.88% 28
2017
Q4
$2.53M Buy
+11,462
New +$2.43M 2.1% 23

Other funds holding UNH

Broadleaf Partners's UNH Position: Q2 2024 in Review

Broadleaf Partners sold out of UnitedHealth (UNH) in Q2 2024, closing a stake of 7,131 shares — an estimated $3.53M sold.

Broadleaf Partners first reported a position in UNH in Q4 2017 and held it in 26 quarters. The position peaked at $7.64M in Q4 2022. 3,395 funds tracked by Wall St. Rank hold UNH as of Q2 2024.

  • Broadleaf Partners reported no remaining UnitedHealth position as of Q2 2024 after selling out during the quarter.
  • Broadleaf Partners sold 7,131 UnitedHealth shares in Q2 2024, an estimated $3.53M.
  • Broadleaf Partners first reported a position in UnitedHealth in Q4 2017 and held it in 26 quarters.
  • Broadleaf Partners's UnitedHealth position peaked at $7.64M in Q4 2022.
  • 3,395 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2024.

Based on Broadleaf Partners's 13F filing for Q2 2024, filed 12 Aug 2024.